Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
59,473.00
50,491.05
41,922.58
42,426.28
30,523.48
40,825.82
33,910.06
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
59,473.00
50,491.05
41,922.58
42,426.28
30,523.48
40,825.82
33,910.06
Raw Material Cost
38,292.00
32,931.15
27,715.49
28,940.59
23,144.77
27,124.76
22,932.11
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
205.00
148.44
125.02
90.50
85.52
86.28
59.80
Selling and Distribution Expenses
16,805.00
14,459.75
12,790.59
11,819.15
11,138.69
11,982.98
9,248.99
Other Expenses
0.00
13.77
6.19
23.61
22.84
36.41
23.78
Total Expenditure (Excl Depreciation)
55,302.00
47,677.02
40,692.98
41,086.32
34,597.43
39,558.16
32,478.72
Operating Profit (PBDIT) excl Other Income
4171
2814
1229.6
1340
-4074
1267.7
1431.3
Other Income
-83.00
87.57
79.56
60.02
234.32
16.68
245.17
Operating Profit (PBDIT)
7,847.00
6,124.92
4,177.87
4,342.84
-868.81
4,507.05
4,354.16
Interest
205.00
148.44
125.02
90.50
85.52
86.28
59.80
Exceptional Items
-624.00
36.55
52.36
513.26
1,021.00
141.11
109.82
Gross Profit (PBDT)
21,181.00
17,559.90
14,207.08
13,485.69
7,378.71
13,701.06
10,977.94
Depreciation
3,759.00
3,223.32
2,868.71
2,942.87
2,970.81
3,222.71
2,677.65
Profit Before Tax
3,259.00
2,789.71
1,236.50
1,822.73
-2,904.15
1,339.17
1,726.53
Tax
1,479.00
1,060.77
541.19
648.01
-558.99
650.20
753.72
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,723.00
1,627.33
607.57
1,074.45
-2,423.17
694.97
976.30
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,723.00
1,627.33
607.57
1,074.45
-2,423.17
694.97
976.30
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
56.00
101.61
87.74
100.28
78.01
-6.00
-3.49
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,779.00
1,728.94
695.31
1,174.72
-2,345.16
688.97
972.82
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
11,431.00
10,427.37
9,118.10
8,608.62
7,561.73
10,162.11
9,901.61
Earnings per share (EPS)
173.41
164.01
61.38
108.67
-244.76
69.78
97.99
Diluted Earnings per share
173.41
164.01
61.38
108.67
-244.76
69.78
97.99
Operating Profit Margin (Excl OI)
7.01%
5.57%
2.93%
3.16%
-13.35%
3.11%
4.22%
Gross Profit Margin
11.8%
11.91%
9.79%
11.23%
0.22%
11.17%
12.99%
PAT Margin
2.9%
3.22%
1.45%
2.53%
-7.94%
1.7%
2.88%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 17.79% vs 20.44% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 2.90% vs 148.66% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 31.35% vs 47.31% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 38.14% vs 18.72% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Hibino Corp. With
Figures in Million
Consolidate Annual Results
Change(JPY)
Change(%)
Net Sales
59,473.00
2,21,755.00
-1,62,282.00
-73.18%
Other Operating Income
0.00
0.00
0.00
Total Operating income
59,473.00
2,21,755.00
-1,62,282.00
-73.18%
Raw Material Cost
38,292.00
1,85,047.00
-1,46,755.00
-79.31%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
205.00
42.00
163.00
388.10%
Selling and Distribution Expenses
16,805.00
22,951.00
-6,146.00
-26.78%
Other Expenses
0.00
33.50
-33.50
-100.00%
Total Expenditure (Excl Depreciation)
55,302.00
2,08,375.00
-1,53,073.00
-73.46%
Operating Profit (PBDIT) excl Other Income
4,171.00
13,380.00
-9,209.00
-68.83%
Other Income
-83.00
721.00
-804.00
-111.51%
Operating Profit (PBDIT)
7,847.00
15,081.00
-7,234.00
-47.97%
Interest
205.00
42.00
163.00
388.10%
Exceptional Items
-624.00
-106.00
-518.00
-488.68%
Gross Profit (PBDT)
21,181.00
36,708.00
-15,527.00
-42.30%
Depreciation
3,759.00
1,257.00
2,502.00
199.05%
Profit Before Tax
3,259.00
13,676.00
-10,417.00
-76.17%
Tax
1,479.00
4,795.00
-3,316.00
-69.16%
Provisions and contingencies
0
0
0.00
Profit After Tax
1,723.00
8,842.00
-7,119.00
-80.51%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,723.00
8,842.00
-7,119.00
-80.51%
Share in Profit of Associates
0
0
0.00
Minority Interest
56.00
39.00
17.00
43.59%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,779.00
8,881.00
-7,102.00
-79.97%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
11,431.00
79,766.00
-68,335.00
-85.67%
Earnings per share (EPS)
173.41
277.64
-104.23
-37.54%
Diluted Earnings per share
173.41
277.64
-104.23
-37.54%
Operating Profit Margin (Excl OI)
7.01%
5.91%
0.00
1.10%
Gross Profit Margin
11.80%
6.73%
0.00
5.07%
PAT Margin
2.90%
3.99%
0.00
-1.09%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 5,947.30 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 17.79% vs 20.44% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 177.90 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 2.90% vs 148.66% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 793.00 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 31.35% vs 47.31% in Mar 2024
Annual - Interest
Interest 20.50 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 38.14% vs 18.72% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 7.01%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024






